Jointown Pharmaceutical Group Company Limited’s Net Profit Dropped 1.9% in First Three Quarters of 2021

Jointown Pharmaceutical Group Company Limited (九州通医药集团股份有限公司) (600998.SH) reported a net profit of 2.5 billion yuan in the first three quarters of 2021, down 1.9% year-on-year.

Meanwhile, the company posted 92.1 billion yuan in revenue, up 14.7% year-on-year.

At the end of the reporting period, it had 86.8 billion yuan in total assets and 59.8 billion yuan in total liabilities, with a liability-to-asset ratio of 68.9%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.